SBSara Boyd

Sara Boyd

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sara Boyd has a total of 3 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    HIV Pre-Exposure Prophylaxis Use Among South Asian Sexual Minority Men in the United States: Pilot Web-Based Survey Study

    by Akshay Sharma, Sara Boyd, Gregory Sallabank

    Background: South Asian American gay, bisexual, and other men who have sex with men (GBM) experience multiple minority stressors, such as internalized homophobia, racial prejudice, and homonegative discrimination, thereby elevating their risk of HIV. Due to the scarcity of HIV scientific literature focusing on South Asian American GBM, little is known about their use of pre-exposure prophylaxis (PrEP) or the upstream factors influencing its uptake. Objective: This study seeks to address this gap by describing PrEP use history among South Asian American GBM and comparing PrEP users and nonusers with respect to their demographic and behavioral characteristics, as well as PrEP knowledge, attitudes, stigma, social norms, and self-efficacy—elements that reflect key constructs of the information-motivation-behavioral (IMB) skills model. Methods: Sexually active South Asian American GBM were recruited from across the United States via social media advertising and peer referral and were administered a Qualtrics survey, for which they received a US $25 Amazon e-gift card. In addition to demographic and behavioral variables, the survey included previously validated scales to measure IMB model constructs. Fisher exact tests and Mann-Whitney U tests were conducted to compare the demographic and behavioral characteristics of PrEP users with nonusers, as well as their scores on each scale, respectively. Results: Of the 103 participants, 34 (33%) were currently using PrEP, 52 (50%) had never used it, and 17 (17%) had discontinued its use. Greater proportions of PrEP users were in open relationships ( P <.001), had at least 2 male sex partners in the past 6 months ( P <.001), and had condomless anal sex with at least 2 male partners in the past 6 months ( P <.001). Frequently cited reasons for never using or discontinuing PrEP included being in or starting a relationship, respectively, and concern about its long-term safety. Consistent with the IMB model, PrEP users exhibited greater PrEP knowledge ( P <.001), stronger motivational elements (PrEP attitudes P =.002; PrEP stigma P =.09; PrEP subjective norms P =.003; PrEP descriptive norms P =.06), and higher PrEP self-efficacy ( P =.003). Conclusions: Suboptimal PrEP use among South Asian American GBM, despite high PrEP knowledge, positive attitudes, low stigma, positive social norms, and high PrEP self-efficacy, represents a disconnect between individual readiness and actual use. Future research exploring their sexual health needs through an intersectional lens could help identify possible points for intervention.

  • Open Access

    Feasibility and Acceptability of a Motivational Interviewing–Based Telehealth Intervention for Bacterial Sexually Transmitted Infection Screening: Protocol for a Sequential Explanatory Mixed Methods Study

    by Akshay Sharma, Sara Boyd, Erin Elizabeth Bonar

    Background: Gay, bisexual, and other men who have sex with men living with HIV (GBMSM-LWH) in the United States bear a heavy burden of bacterial sexually transmitted infections (STIs). Timely diagnosis and treatment are key to prevention. Only a few studies have combined home specimen self-collection for bacterial STI screening with live audio and video (AV) conferencing. None have focused on GBMSM-LWH or incorporated motivational interviewing (MI), a client-centered, strengths-based counseling approach that seeks to support individuals to create positive behavioral change. Objective: Our study seeks to investigate the feasibility and acceptability of an MI-based telehealth intervention that integrates home specimen self-collection from different anatomical sites of possible exposure and MI delivered via live AV conferencing to engage sexually active GBMSM-LWH in bacterial STI screening. Methods: Participants are being recruited from across the United States via advertising on mobile dating apps and social networking sites and via peer referral. Phase 1 involves piloting the delivery of an innovative telehealth intervention for bacterial STI screening to 75 GBMSM-LWH. Our intervention includes three components: (1) a pretest live AV conferencing session involving an MI-guided discussion to elicit awareness of bacterial STIs; fill any knowledge gaps; bolster the perceived importance of regularly testing for gonorrhea, chlamydia, and syphilis; and build self-efficacy for specimen self-collection; (2) home self-collection and return via mail of a urine sample (for gonorrhea and chlamydia testing), a throat swab (for gonorrhea and chlamydia testing), a rectal swab (for gonorrhea and chlamydia testing), and a finger-stick blood sample (for syphilis testing); and (3) a posttest live AV conferencing session involving an MI-guided discussion to prepare participants for receiving test results and formulate personalized action plans for seeking treatment (if warranted) and repeat testing. Descriptive statistics and progression ratios will be calculated, and potential variations in our intervention’s feasibility and acceptability will be numerically summarized and graphically visualized. Phase 2 involves elucidating attitudes, facilitators, and barriers related to engaging in each intervention component via semistructured in-depth interviews with a purposive subsample of 20 participants who complete progressively smaller subsets of the pretest session, specimen return for bacterial STI testing, and the posttest session. Thematic analysis will be used to identify, analyze, and report patterns in the data. Quantitative and qualitative data will be integrated at the design, methods, interpretation, and reporting levels. Results: Study procedures were approved by the Institutional Review Board at the University of Michigan in September 2023. Participant recruitment began in April 2024. Conclusions: Our study will advance multiple goals of the STI National Strategic Plan for the United States for 2021 to 2025, specifically those pertaining to preventing new STIs; accelerating progress in STI research, technology, and innovation; and reducing STI-related health disparities. Trial Registration: ClinicalTrials.gov NCT06100250; https://www.clinicaltrials.gov/study/NCT06100250 International Registered Report Identifier (IRRID): DERR1-10.2196/64433


  • Open Access

    Feasibility and Acceptability of a Motivational Interviewing–Based Telehealth Intervention for Bacterial Sexually Transmitted Infection Screening: Protocol for a Sequential Explanatory Mixed Methods Study (Preprint)

    by Akshay Sharma, Sara Boyd, Erin Elizabeth Bonar

    BACKGROUND Gay, bisexual, and other men who have sex with men living with HIV (GBMSM-LWH) in the United States bear a heavy burden of bacterial sexually transmitted infections (STIs). Timely diagnosis and treatment are key to prevention. Only a few studies have combined home specimen self-collection for bacterial STI screening with live audio and video (AV) conferencing. None have focused on GBMSM-LWH or incorporated motivational interviewing (MI), a client-centered, strengths-based counseling approach that seeks to support individuals to create positive behavioral change. OBJECTIVE Our study seeks to investigate the feasibility and acceptability of an MI-based telehealth intervention that integrates home specimen self-collection from different anatomical sites of possible exposure and MI delivered via live AV conferencing to engage sexually active GBMSM-LWH in bacterial STI screening. METHODS Participants are being recruited from across the United States via advertising on mobile dating apps and social networking sites and via peer referral. Phase 1 involves piloting the delivery of an innovative telehealth intervention for bacterial STI screening to 75 GBMSM-LWH. Our intervention includes three components: (1) a pretest live AV conferencing session involving an MI-guided discussion to elicit awareness of bacterial STIs; fill any knowledge gaps; bolster the perceived importance of regularly testing for gonorrhea, chlamydia, and syphilis; and build self-efficacy for specimen self-collection; (2) home self-collection and return via mail of a urine sample (for gonorrhea and chlamydia testing), a throat swab (for gonorrhea and chlamydia testing), a rectal swab (for gonorrhea and chlamydia testing), and a finger-stick blood sample (for syphilis testing); and (3) a posttest live AV conferencing session involving an MI-guided discussion to prepare participants for receiving test results and formulate personalized action plans for seeking treatment (if warranted) and repeat testing. Descriptive statistics and progression ratios will be calculated, and potential variations in our intervention’s feasibility and acceptability will be numerically summarized and graphically visualized. Phase 2 involves elucidating attitudes, facilitators, and barriers related to engaging in each intervention component via semistructured in-depth interviews with a purposive subsample of 20 participants who complete progressively smaller subsets of the pretest session, specimen return for bacterial STI testing, and the posttest session. Thematic analysis will be used to identify, analyze, and report patterns in the data. Quantitative and qualitative data will be integrated at the design, methods, interpretation, and reporting levels. RESULTS Study procedures were approved by the Institutional Review Board at the University of Michigan in September 2023. Participant recruitment began in April 2024. CONCLUSIONS Our study will advance multiple goals of the STI National Strategic Plan for the United States for 2021 to 2025, specifically those pertaining to preventing new STIs; accelerating progress in STI research, technology, and innovation; and reducing STI-related health disparities. CLINICALTRIAL ClinicalTrials.gov NCT06100250; https://www.clinicaltrials.gov/study/NCT06100250 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/64433